NCT01724814: A First-in-human Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of HM12460A |
|
|
| Completed | 1 | 86 | US | HM12460A, LAPS-Insulin, Placebo | Hanmi Pharmaceutical Company Limited | Healthy, Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus | 07/14 | 07/14 | | |
